Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 42
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Phase II Study of TS-1 Therapy and TS-1+PSK Therapy Against Advanced Gastric Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Active
20 and over
Other
ENCITJ-GC01
NCT00503321
2.
Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Active
20 and over
Other
JACCRO GC-05
NCT00639327
Last Modified:
5/8/2008
 
First Published:
8/5/2005
3.
Phase III Randomized Study of S-1 and Cisplatin Versus Fluorouracil and Cisplatin in Patients With Unresectable Locally Advanced or Metastatic Gastric Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
18 and over
Pharmaceutical / Industry
TAIHO-TPU-S1301
QUINT-TPU-S1301, NCT00400179
4.
Randomized Controlled Study of Postoperative Adjuvant Therapy for Gastric Cancer Using TS-1 or TS-1+PSK
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
20 to 80
Other
HKIT-GC
NCT00216034
5.
Study Evaluating Isovorin in Advanced/Recurrent Gastric Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
20 to 77
Pharmaceutical / Industry
ISO/5FU-10
NCT00195572
6.
A Trial of Neoadjuvant TS-1 and Cisplatin for Type 4 and Large Type 3 Gastric Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
20 to 75
Other
JCOG0501
C000000279, NCT00252161
7.
Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
20 to 79
Other
JACCRO GC-03
NCT00287768
Last Modified:
9/11/2008
 
First Published:
6/9/2006
8.
Phase III Randomized Study of Adjuvant Chemotherapy Comprising S-1 Versus Tegafur-Uracil (UFT) in Patients With Definitively Treated Stage III or IV Squamous Cell Carcinoma of the Head and Neck
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
20 to 75
Other
YCU-BRI-HN-05-01
NCT00336947
9.
Phase III of Gemcitabine Vs TS-1 Vs Gemcitabine Plus TS-1 in Pancreatic Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
20 and over
Pharmaceutical / Industry
01023017
NCT00498225
Last Modified:
9/15/2008
 
First Published:
4/15/2008
10.
Phase III Randomized Study of Adjuvant Tegafur-Uracil and Leucovorin Calcium Versus S-1 in Patients With Resected Stage III Colon Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Biomarker/Laboratory analysis, Treatment
Active
20 to 80
Other
TMDU-TRICC0706
TRICC0706, NCT00660894
Select All on One Page
1
2
3
4
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute